{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "regularMarketChange": -0.029999971, "regularMarketTime": 1683892036, "regularMarketDayHigh": 1.23, "regularMarketDayRange": "1.2 - 1.23", "regularMarketDayLow": 1.2, "regularMarketVolume": 700, "regularMarketPreviousClose": 1.26, "bid": 1.23, "ask": 1.28, "bidSize": 900, "askSize": 900, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 1.23, "averageDailyVolume3Month": 20, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.3, "fiftyTwoWeekLowChangePercent": 0.32258067, "fiftyTwoWeekRange": "0.93 - 2.52", "fiftyTwoWeekHighChange": -1.29, "fiftyTwoWeekHighChangePercent": -0.5119048, "fiftyTwoWeekLow": 0.93, "fiftyTwoWeekHigh": 2.52, "exchange": "FRA", "shortName": "ADAPTH.TH.SP.ADR6 LS-,001", "longName": "Adaptimmune Therapeutics plc", "messageBoardId": "finmb_113495056", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -2.3809502, "regularMarketPrice": 1.23, "earningsTimestamp": 1683892800, "earningsTimestampStart": 1683892800, "earningsTimestampEnd": 1683892800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.96, "epsForward": -1.0, "epsCurrentYear": -0.98, "priceEpsCurrentYear": -1.255102, "sharesOutstanding": 165702000, "bookValue": 0.498, "fiftyDayAverage": 1.1746, "fiftyDayAverageChange": 0.055400014, "fiftyDayAverageChangePercent": 0.047165003, "twoHundredDayAverage": 1.5494, "twoHundredDayAverageChange": -0.31939995, "twoHundredDayAverageChangePercent": -0.20614429, "marketCap": 205457984, "forwardPE": -1.23, "priceToBook": 2.4698796, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.7 - Hold", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1433138400000, "priceHint": 4, "symbol": "473A.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "60 Jubilee Avenue", "address2": "Milton Park", "city": "Abingdon", "zip": "OX14 4RX", "country": "United Kingdom", "phone": "44 12 3543 0000", "fax": "44 12 3543 0001", "website": "https://www.adaptimmune.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops SPEARHEAD-1 that is in phase II clinical trials with ADP-A2M4 for synovial sarcoma; SURPASS-3 that is in phase II clinical trial with ADP-A2M4CD8 for people with platinum resistant ovarian cancer; and SURPASS that is in phase I clinical trials in patients with head and neck, and urothelial cancers. The company has strategic collaboration and license agreement with Genentech, Inc. and F. Hoffman-La Roche Ltd to develop personalized allogeneic and allogeneic T-cell therapies; co-development collaboration agreement with Universal Cells, Inc.; third-party collaborations with Noile-Immune and Alpine Immune Sciences; and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.", "fullTimeEmployees": 534, "companyOfficers": [{"maxAge": 1, "name": "Mr. Adrian G.  Rawcliffe", "age": 50, "title": "CEO, Principal Accounting Officer & Director", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 693645, "fmt": "693.64k", "longFmt": "693,645"}, "exercisedValue": {"raw": 273278, "fmt": "273.28k", "longFmt": "273,278"}, "unexercisedValue": {"raw": 5640949, "fmt": "5.64M", "longFmt": "5,640,949"}}, {"maxAge": 1, "name": "Mr. Gavin Hilary James Wood BA (Hons), ACA", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 508221, "fmt": "508.22k", "longFmt": "508,221"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1849966, "fmt": "1.85M", "longFmt": "1,849,966"}}, {"maxAge": 1, "name": "Mr. William C. Bertrand Jr., Esq., J.D.", "age": 57, "title": "Chief Operating Officer", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 573798, "fmt": "573.8k", "longFmt": "573,798"}, "exercisedValue": {"raw": 132353, "fmt": "132.35k", "longFmt": "132,353"}, "unexercisedValue": {"raw": 2448122, "fmt": "2.45M", "longFmt": "2,448,122"}}, {"maxAge": 1, "name": "Dr. Elliot  Norry B.A., M.D.", "age": 58, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 549049, "fmt": "549.05k", "longFmt": "549,049"}, "exercisedValue": {"raw": 70860, "fmt": "70.86k", "longFmt": "70,860"}, "unexercisedValue": {"raw": 455520, "fmt": "455.52k", "longFmt": "455,520"}}, {"maxAge": 1, "name": "Dr. Helen Katrina Tayton-Martin MBA, Ph.D.", "age": 55, "title": "Co-Founder & Chief Bus. & Strategy Officer", "yearBorn": 1967, "fiscalYear": 2021, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Joanna  Brewer Ph.D.", "age": 46, "title": "Chief Scientific Officer", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Juli P. Miller Ph.D.", "title": "VP of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Kerry  Sharp", "title": "Sr. VP & Gen. Council", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. S\u00e9bastien  Desprez", "title": "VP of Communications & Corp. Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Rafael G.  Amado M.D.", "age": 58, "title": "Pres of R&D", "yearBorn": 1964, "fiscalYear": 2018, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}